| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
|  | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc. | 
| First Approval Date07 Apr 2014 | 
|  | 
|  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc. | 
| First Approval Date24 Jan 2003 | 
|  | 
|  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.United States | 
| First Approval Date30 Apr 1996 | 
100 Clinical Results associated with Eurocept International B.V.
0  Patents (Medical) associated with Eurocept International B.V.
100 Deals associated with Eurocept International B.V.
100 Translational Medicine associated with Eurocept International B.V.